This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ranheim, T S
Right arrow Articles by Wold, W S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ranheim, T S
Right arrow Articles by Wold, W S

 Previous Article  |  Next Article 

J Virol. 1993 April; 67(4): 2159-2167

Characterization of mutants within the gene for the adenovirus E3 14.7-kilodalton protein which prevents cytolysis by tumor necrosis factor.

T S Ranheim, J Shisler, T M Horton, L J Wold, L R Gooding and W S Wold

Department of Molecular Microbiology and Immunology, St. Louis University School of Medicine, Missouri 63104.

ABSTRACT

The 14,700-Da protein (14.7K protein) encoded by the E3 region of adenovirus has previously been shown to protect mouse cells from cytolysis by tumor necrosis factor (TNF). Delineating the sequences in the 14.7K protein that are required for this activity may provide insight into the mechanism of protection from TNF by 14.7K as well as the mechanism of TNF cytolysis. In the present study, we examined the ability of 14.7K mutants to protect cells from lysis by TNF. In-frame deletions as well as Cys-to-Ser mutations in the 14.7K gene were generated by site-directed mutagenesis and then built into the genome of a modified adenovirus type 5 (dl7001) that lacks all E3 genes. dl7001, which replicates to the same titers as does adenovirus type 5 in cultured cells, has the largest E3 deletion analyzed to date. 51Cr release was used to assay TNF cytolysis. Our results indicate that most mutations in the 14.7K gene result in a loss of function, suggesting that nearly the entire protein rather than a specific domain functions to prevent TNF cytolysis.

J Virol. 1993 April; 67(4): 2159-2167




This article has been cited by other articles:

  • Sheehan, K. A., Ke, Y., Wolska, B. M., Solaro, R. J. (2009). Expression of active p21-activated kinase-1 induces Ca2+ flux modification with altered regulatory protein phosphorylation in cardiac myocytes. Am. J. Physiol. Cell Physiol. 296: C47-C58 [Abstract] [Full Text]  
  • Tollefson, A. E., Ying, B., Doronin, K., Sidor, P. D., Wold, W. S. M. (2007). Identification of a New Human Adenovirus Protein Encoded by a Novel Late l-Strand Transcription Unit. J. Virol. 81: 12918-12926 [Abstract] [Full Text]  
  • McConnell, M. J., Hanna, P. C., Imperiale, M. J. (2006). Cytokine Response and Survival of Mice Immunized with an Adenovirus Expressing Bacillus anthracis Protective Antigen Domain 4. Infect. Immun. 74: 1009-1015 [Abstract] [Full Text]  
  • Ke, Y., Wang, L., Pyle, W. G., de Tombe, P. P., Solaro, R. J. (2004). Intracellular Localization and Functional Effects of P21-Activated Kinase-1 (Pak1) in Cardiac Myocytes. Circ. Res. 94: 194-200 [Abstract] [Full Text]  
  • Tarakanova, V. L., Wold, W. S. M. (2003). Transforming Growth Factor {beta}1 Receptor II Is Downregulated by E1A in Adenovirus-Infected Cells. J. Virol. 77: 9324-9336 [Abstract] [Full Text]  
  • Sauter, E. R., Yeo, U.-C., von Stemm, A., Zhu, W., Litwin, S., Tichansky, D. S., Pistritto, G., Nesbit, M., Pinkel, D., Herlyn, M., Bastian, B. C. (2002). Cyclin D1 Is a Candidate Oncogene in Cutaneous Melanoma. Cancer Res. 62: 3200-3206 [Abstract] [Full Text]  
  • Friedman, J. M., Horwitz, M. S. (2002). Inhibition of Tumor Necrosis Factor Alpha-Induced NF-{kappa}B Activation by the Adenovirus E3-10.4/14.5K Complex. J. Virol. 76: 5515-5521 [Abstract] [Full Text]  
  • Tollefson, A. E., Toth, K., Doronin, K., Kuppuswamy, M., Doronina, O. A., Lichtenstein, D. L., Hermiston, T. W., Smith, C. A., Wold, W. S. M. (2001). Inhibition of TRAIL-Induced Apoptosis and Forced Internalization of TRAIL Receptor 1 by Adenovirus Proteins. J. Virol. 75: 8875-8887 [Abstract] [Full Text]  
  • Sijts, A. J. A. M., Standera, S., Toes, R. E. M., Ruppert, T., Beekman, N. J. C. M., van Veelen, P. A., Ossendorp, F. A., Melief, C. J. M., Kloetzel, P. M. (2000). MHC Class I Antigen Processing of an Adenovirus CTL Epitope Is Linked to the Levels of Immunoproteasomes in Infected Cells. J. Immunol. 164: 4500-4506 [Abstract] [Full Text]  
  • Hsu, M.-Y., Meier, F. E., Nesbit, M., Hsu, J.-Y., Van Belle, P., Elder, D. E., Herlyn, M. (2000). E-Cadherin Expression in Melanoma Cells Restores Keratinocyte-Mediated Growth Control and Down-Regulates Expression of Invasion-Related Adhesion Receptors. Am. J. Pathol. 156: 1515-1525 [Abstract] [Full Text]  
  • Sauter, E. R., Herlyn, M., Liu, S.-C., Litwin, S., Ridge, J. A. (2000). Prolonged Response to Antisense Cyclin D1 in a Human Squamous Cancer Xenograft Model. Clin. Cancer Res. 6: 654-660 [Abstract] [Full Text]  
  • Hsu, M, Andl, T, Li, G, Meinkoth, J., Herlyn, M (2000). Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. J. Cell Sci. 113: 1535-1542 [Abstract]  
  • Sauter, E. R., Nesbit, M., Litwin, S., Klein-Szanto, A. J. P., Cheffetz, S., Herlyn, M. (1999). Antisense Cyclin D1 Induces Apoptosis and Tumor Shrinkage in Human Squamous Carcinomas. Cancer Res. 59: 4876-4881 [Abstract] [Full Text]  
  • Chen, P., Tian, J., Kovesdi, I., Bruder, J. T. (1998). Interaction of the Adenovirus 14.7-kDa Protein with FLICE Inhibits Fas Ligand-induced Apoptosis. J. Biol. Chem. 273: 5815-5820 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»